EDGAR Filing Documents for 0001493152-15-002051

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001493152-15-002051

Filing Date

2015-05-15

Accepted

2015-05-15 18:57:10

Documents

Period of Report

2015-05-13

Document Format Files

Seq	Description	Document	Type	Size
1		form4.html	4
1		form4.xml	4	3602
	Complete submission text file	0001493152-15-002051.txt		5150

Mailing Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121

Business Address

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 15871369

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130

Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042

Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations